Ensure healthy pregnancies with advanced preimplantation genetic testing (PGT / PGS) at Erdem Hospital, where science and compassion come together to provide couples with peace of mind and improved fertility outcomes.
For many couples undergoing IVF or ICSI, concerns about genetic disorders or chromosomal abnormalities are significant. Preimplantation Genetic Testing (PGT) previously known as Preimplantation Genetic Screening (PGS) offers a powerful solution. By analyzing embryos before transfer, PGT identifies genetic abnormalities that may lead to implantation failure, miscarriage, or inherited conditions.
At Erdem Hospital, this testing is integrated into IVF and ICSI cycles to ensure that only chromosomally healthy embryos are selected for transfer. This improves pregnancy rates, reduces the risk of miscarriage, and provides reassurance for couples with known genetic risks or a history of failed fertility treatments.
Turkey has become a preferred destination for international patients seeking PGT, combining advanced laboratory technology with affordability and comprehensive care.
A complete PGT package at Erdem Hospital typically includes:
This all-in-one approach ensures couples feel guided, supported, and reassured throughout the entire process.
The cost of PGT can vary widely across countries.
This makes Turkey one of the most cost-effective destinations for advanced genetic fertility services.
The preimplantation genetic testing process at Erdem Hospital is integrated into the IVF cycle with careful precision:
This process typically extends the IVF timeline by a few days, but it greatly enhances safety and success.
Couples who undergo PGT often share that the process gave them reassurance and reduced the emotional stress of uncertainty.
Some common reflections include:
These voices underline how PGT is not only a medical advancement but also a source of emotional relief.
What is the difference between PGT and PGS?
PGS is the older term for screening embryos for chromosomal abnormalities. Today, PGT is the broader term that includes both chromosomal screening (PGT-A) and testing for specific genetic conditions (PGT-M).
Who should consider PGT?
Couples with recurrent miscarriages, advanced maternal age, failed IVF attempts, or known hereditary conditions are ideal candidates.
Does PGT guarantee a healthy baby?
PGT reduces the risk of genetic abnormalities but cannot guarantee a healthy baby. It significantly increases the chances of successful pregnancy.
Is embryo biopsy safe?
Yes, when performed by experienced specialists, embryo biopsy is considered safe and does not harm the embryo’s ability to implant and grow.
How many embryos are usually tested?
The number depends on ovarian response and fertilization success. Multiple embryos can be tested in a single cycle.
Can frozen embryos be tested later?
Yes, previously frozen embryos can be thawed, biopsied, and refrozen for genetic testing.
For couples embarking on the journey to parenthood through assisted reproductive technologies, the hope of achieving a healthy pregnancy is often accompanied by understandable concerns. Questions about genetic health, potential risks, and the chances of miscarriage weigh heavily on many families. Preimplantation Genetic Testing (PGT) has emerged as one of the most significant innovations in fertility care, offering reassurance, precision, and peace of mind.
At Erdem Hospital, PGT is seamlessly integrated into IVF and ICSI treatments. Guided by over 37 years of medical expertise, this advanced service ensures that embryos can be tested for genetic health before transfer, giving couples the confidence that they are taking every step possible toward achieving a safe and successful pregnancy. By combining science with compassion and accessibility, Erdem Hospital empowers families from all over the world to move forward with clarity and hope.
Preimplantation Genetic Testing, or PGT, is a procedure performed during an IVF or ICSI cycle that screens embryos for genetic abnormalities before they are transferred to the uterus. By identifying embryos with normal chromosome numbers or specific genetic characteristics, PGT significantly reduces the risk of miscarriage and increases the chances of delivering a healthy baby.
Modern PGT relies on sophisticated laboratory techniques, allowing embryologists to examine embryos at a cellular level. A few cells are carefully biopsied from the embryo on the fifth or sixth day of development, then analyzed using advanced genetic technologies. Importantly, this process does not damage the embryo, which can be safely frozen and later transferred once results are confirmed.
There are different forms of PGT, each addressing specific concerns:
By tailoring the type of PGT to each couple’s medical background, fertility specialists at Erdem Hospital ensure the most effective and appropriate testing pathway is chosen.
PGT is not limited to a specific group of patients; it is a valuable option for many couples pursuing assisted reproduction. The most common candidates include:
This broad scope makes PGT one of the most versatile tools in fertility medicine, offering hope to couples who may otherwise feel uncertain about their prospects.
At Erdem Hospital, the PGT journey is designed to be transparent and supportive, ensuring patients understand each stage of the process.
By combining meticulous laboratory practices with advanced genetic technology, Erdem Hospital ensures that the PGT process is both safe and effective.
PGT offers multiple advantages that extend beyond traditional IVF or ICSI outcomes:
These benefits demonstrate why PGT is increasingly recommended in fertility centers worldwide as a cornerstone of modern reproductive care.
While PGT offers profound advantages, the emotional journey of couples undergoing testing is equally important. The decision to screen embryos can bring a sense of relief but also raise new questions. Will there be enough healthy embryos? What if results are unexpected?
At Erdem Hospital, emotional support is integrated into every stage of treatment. Fertility specialists take time to explain results, guide couples through decision-making, and provide reassurance during what can be a highly sensitive process. By addressing both the medical and emotional dimensions, patients feel empowered to move forward with confidence.
The accuracy and safety of PGT depend heavily on the expertise of the medical and laboratory team. Embryo biopsy requires delicate precision, and genetic analysis must be interpreted correctly to ensure reliable outcomes.
Erdem Hospital brings over 37 years of expertise in reproductive medicine, combining skilled embryologists, advanced laboratories, and internationally recognized fertility specialists. This wealth of experience ensures that patients receive world-class standards of care while benefiting from a supportive and compassionate environment.
As reproductive technology continues to advance, PGT is becoming increasingly central to fertility care. Beyond its current applications, researchers are exploring ways to integrate even more sophisticated genetic insights, potentially identifying embryo health at a deeper level.
For couples today, however, the impact of PGT is already transformative. By combining IVF or ICSI with genetic screening, they gain not only higher chances of success but also the reassurance that their journey is grounded in science, safety, and informed choice.
Preimplantation Genetic Testing is more than a laboratory procedure it is a tool of empowerment. It gives couples reassurance that they are making the best possible decisions for their future family. Whether used to reduce miscarriage risk, avoid passing on genetic conditions, or increase the success of IVF and ICSI, PGT represents clarity and confidence in a journey often filled with uncertainty.
At Erdem Hospital, every PGT cycle is guided by precision, compassion, and over three decades of expertise. By integrating advanced science with patient-centered care, the hospital provides couples from around the world with the opportunity to move forward on their path to parenthood with renewed hope and trust.